IFNγ sensitization to TRAIL-induced apoptosis in human thyroid carcinoma cells by upregulating Bak expression

Oncogene

Volumn 23, Issue 4, 2004, Pages 928-935

  Wang, Su He ^a   Mezosi, Emese ^a   Wolf, Julie M ^a   Cao, Zhengyi ^a   Utsugi, Saho ^a   Gauger, Paul G ^a   Doherty, Gerard M ^a   Baker Jr , James R ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Apoptosis; Bak; IFN ; Thyroid cancer; TRAIL

Indexed keywords

GAMMA INTERFERON; PROTEIN BAK; PROTEIN BCL 2; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; APOPTOSIS REGULATORY PROTEIN; BAK1 PROTEIN, HUMAN; BAK1 PROTEIN, MOUSE; MEMBRANE PROTEIN; TNFSF10 PROTEIN, HUMAN; TNFSF10 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID CARCINOMA; THYROID TUMOR; UPREGULATION; ANIMAL; DNA MICROARRAY; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALIA;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; CELL LINE, TUMOR; HUMANS; INTERFERON TYPE II; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; THYROID NEOPLASMS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 1342301477     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207213     Document Type: Article

References (39)

1. Ain KB. (1998). Thyroid, 9, 715-725.
2. Ain KB, Egorin MJ and DeSimone PA. (2000). Thyroid, 10, 587-594.
3. Beatty GL and Paterson Y. (2001). Immunol. Res., 24, 201-210.
4. Bonavida B, Ng CP, Jazirehi A, Schiller G and Mizutani Y. (1999). Intl. J. Oncol., 15, 793-802.
5. Braga-Basaria M and Ringel M. (2003). J. Clin. Endocrinol. Metab., 88, 1947-1960.
6. Bretz JD, Arscott PL, Myc A and Baker Jr JR. (1999a). J. Biol. Chem., 274, 25433-25438.
7. Bretz JD, Rymaszewski M, Arscott PL, Myc A, Ain KB, Thompson NW and Baker Jr JR. (1999b). J. Biol. Chem., 33, 23627-23632.
8. Caturegli P, Hejazi M, Suzuki K, Dohan O, Carrasco N, Kohn LD and Rose R. (2000). Proc. Natl. Acad. Sci., 97, 1719-1724.
9. de Metz J, Romijn JA, Endert E, Corssmit EP and Sauerwein HP. (2000). Thyroid, 10, 87-91.
10. Egle A, Villunger A, Kos M, Bock G, Gruber J, Auer B and Greil R. (1996). Eur. J. Immunol., 26, 3119-3126.
11. Fisher DE. (1994). Cell, 78, 539-542.
12. Fulda S and Debatin KM. (2002). Oncogene, 21, 2295-2308.
13. Jelinek DF, Aagaard-Tillery KM, Arendt BK, Arora T, Tschumper RC and Westendorf JJ. (1997). J. Clin. Invest., 99, 447-456.
14. Kandasamy K, Srinivasula S, Alnemri E, Thompson C, Korsmeyer S, Bryant J and Srivastava R. (2003). Cancer Res., 63, 1712-1721.
15. Kayagaki N, Yamaguchi N, Nakayama M, Kawasaki A, Akiba H, Okumura K and Yagita H. (1999). J. Immunol., 162, 2639-2647.
16. Killinger Jr WA, Dorofi DB, Tinsley Jr EA, Keagy BA and Johnson Jr G. (1992). Ann. Thorac. Surg., 53, 472-476.
17. Kluck RP, Bossy-Wetzel E and Green D. (1997). Science, 275, 1132-1136.
18. Kroemer G. (2001). Bull. Acad. Natl. Med., 185, 1135-1142, discussion 1143.
19. Kumar-Sinha C, Varambally S, Sreekumar A and Chinnaiyan AM. (2002). J. Biol. Chem., 277, 575-585.
20. Langaas V, Shahzidi S, Johnsen JI, Smedsrod B and Sveinbjornsson B. (2001). Anticancer Res., 21, 3733-3738.
21. Lee YS, Bulliard DE and Zalutsky MR. (1988). Cancer Res., 48, 559-565.
22. Mitsiades N, Poulaki V, Tseleni-Balafouta S, Koutras DA and Stamenkovic I. (2000). Cancer Res., 60, 4122-4129.
23. Newton K and Strasser A. (1998). Curr. Opin. Genet. Dev., 8, 68-75.
24. Ossina NK, Cannas A, Powers V, Fitzpatrick PA, Knight JD, Gilbert JR, Shekhtman EM, Tomei LD, Umansky SR and Kiefer MC. (1997). J. Biol Chem., 272, 16351-16357.
25. Pan G, Ni J, Wei Y, Genetz R and Dixit VA. (1997). Science, 277, 111-113.
26. Poulaki V, Mitsiades CS, Kotoula K, Tseleni-Balafouta S, Ashkenazi A, Koutras DA and Mitsiades N. (2002). Am J. Pathol., 162, 643-654.
27. Ruiz-Ruiz C and Lopez-Rivas A. (2002). Biochem. J., 365, 825-832.
28. Sato K, Hida S, Takayanagi H, Yokochi T, Kayagaki N, Takeda K, Yagita H, Okumura K, Tanaka N, Taniguchi T and Ogasawara K. (2001). Eur. J. Immunol., 31, 3138-3146.
29. Shimizu H, Narita M and Tsujimoto Y. (1999). Nature, 399, 483-487.
30. Shin EC, Shin WC, Choi Y, Kim H, Park JH and Kim SJ. (2001). Cancer Immunol. Immunother., 50, 23-30.
31. Simonian PL, Grillot DA and Nunez G. (1997). Oncogene, 15, 1871-1875.
32. Strasser A, O'Connor L and Dixit VM. (2000). Annu. Rev. Biochem., 69, 217-245.
33. Sundararajan R, Cuconati A, Nelson D and White E. (2001). J. Biol. Chem., 276, 45120-45127.
34. Voigt W, Bulankin A, Muller T, Schoeber C, Grothey A, Hoang-Vu C and Schmoll HJ. (2000). Clin. Cancer Res., 6, 2087-2093.
35. Wang SH, Koenig RJ, Giordano TJ, Myc A, Thompson NW and Baker Jr JR. (1999). Endocrinology, 140, 1649-1656.
36. Wang SH, Phelp E, Utsugi S and Baker Jr JR. (2001). Thyroid, 11, 725-731.
37. Wang SH, Bretz JD, Phelps E, Mezosi E, Arscott PL, Utsugi S and Baker Jr JR. (2002). J. Immunol., 168, 2470-2474.
38. Yano H, Fukuda K, Haramaki M, Momosaki S, Ogasawara S, Higaki K and Kojiro M. (1996). J. Hepatol., 25, 454-464.
39. Yeung SCJ, Xu G, Pan J, Christgen M and Bamiagis A. (2000). Cancer Res., 60, 650-656